ATTR Cardiac Amyloidosis
David Wolinsky, MD, Director of the Cardiac Amyloid Clinic at the Cleveland Clinic in Weston, FL, delves into the details of transthyretin amyloidosis (ATTR) and its impact on the heart.
▶︎
Mathew Maurer, MD, FACC | Cardiac Amyloidosis
▶︎
Cardiac Amyloidosis: Update on Diagnosis and Treatment
▶︎
Understanding and Managing ATTR Amyloidosis
▶︎
Cardiac Amyloidosis Webinar
▶︎
Fetal & Neonatal Alloimmune Thrombocytopenia (FNAIT) | Michael J. Paidas, MD
▶︎
Cardiac Amyloidosis: From Heart Failure to Heart Success | Siu-Hin Wan, MD, FACC, FAHA, FHFSA
▶︎
Left Ventricular Noncompaction: A phenotype, not a diagnosis
▶︎
Cardiac Amyloidosis No longer rare and untreatable - Bell-Ezziddine
▶︎
Peripheral and Autonomic Neuropathy in ATTR Amyloidosis
▶︎
Webinar « Cardiac Amyloidosis: All you need to know »
▶︎
Diagnosing and Managing Hypertrophic Cardiomyopathy: A Conversation with Dr. Martin Maron
▶︎
Cardiac Amyloidosis Interpretation Best Practices
▶︎
Evolving Treatment Landscape in Transthyretin Cardiac Amyloidosis
▶︎
Amyloidosis Awareness 2021
▶︎
Understanding Cardiac Amyloidosis: Evaluation and Diagnosis w/ Mathew S. Maurer, MD
▶︎
Amyloidosis Types - Pathology - Quick Review
▶︎
What is cardiac amyloidosis?
▶︎
Mayo Clinic Q&A podcast: Symptoms for cardiac amyloidosis overlap with other conditions
▶︎
Cardiac Amyloidosis by Dr. Mat Maurer
▶︎
Wild-Type Transthyretin Cardiac Amyloidosis - Mayo Clinic
▶︎
AL Amyloidosis Overview by Dr. Morie Gertz
▶︎
Cardiac Amyloidosis: Tc-99m PYP Imaging - How to Do It Right
▶︎
Amyloidosis, Causes, Signs and Symptoms, Diagnosis and Treatment.
▶︎